Related Experiment Video
Updated: Sep 24, 2025
10:23
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
13.8K
MITF deficiency accelerates GNAQ-driven uveal melanoma.
Grace B Phelps1,2, Hannah R Hagen1,2, Adam Amsterdam1,2
1David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139.
Summary
Microphthalmia-associated transcription factor (MITF) acts as a tumor suppressor in uveal melanoma (UM), contrary to its role in cutaneous melanoma (CM). Loss of MITF accelerates UM development by promoting YAP signaling.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Cutaneous melanoma (CM) and uveal melanoma (UM) arise from melanocytes but have distinct drivers (BRAF/NRAS in CM, GNAQ/GNA11 in UM).
- Microphthalmia-associated transcription factor (MITF) is crucial for CM but its role in UM is unclear.
Purpose of the Study:
- To investigate the role of MITF in uveal melanoma (UM) development.
- To identify key oncogenic signaling pathways in UM using zebrafish models.
Main Methods:
- Utilized zebrafish models with patient-derived mutations in GNAQ or CYSLTR2, and tp53.
- Investigated the role of YAP and phospholipase C-β (PLCβ)–ERK pathways.
- Assessed the impact of mitfa deficiency on UM initiation and progression.
Main Results:
- GNAQ/CYSLTR2 mutations combined with tp53 mutations drive UM.
- Activated YAP strongly induced UM, while PLCβ mutations rarely did.
- Mitfa deficiency accelerated UM onset and progression, promoting YAP signaling and suppressing ERK activity.
Conclusions:
- YAP signaling is a major driver of UM.
- MITF functions as a tumor suppressor in UM, opposing its role in CM.
- Understanding MITF's role in UM opens new avenues for targeted therapies.
